Allogene Therapeutics (ALLO) Amortizatization of Intangibles (2019 - 2025)
Allogene Therapeutics (ALLO) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $821000.0 as the latest value for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 50.27% to $821000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 49.44% year-over-year, with the annual reading at $4.2 million for FY2025, 49.44% down from the prior year.
- Amortizatization of Intangibles hit $821000.0 in Q4 2025 for Allogene Therapeutics, down from $923000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.4 million in Q4 2021 to a low of -$1.9 million in Q1 2021.
- Historically, Amortizatization of Intangibles has averaged $824350.0 across 5 years, with a median of $998500.0 in 2023.
- Biggest five-year swings in Amortizatization of Intangibles: crashed 1365.56% in 2021 and later skyrocketed 2214.74% in 2023.
- Year by year, Amortizatization of Intangibles stood at $5.4 million in 2021, then crashed by 102.91% to -$156000.0 in 2022, then surged by 2214.74% to $3.3 million in 2023, then tumbled by 49.95% to $1.7 million in 2024, then plummeted by 50.27% to $821000.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for ALLO at $821000.0 in Q4 2025, $923000.0 in Q3 2025, and $1.2 million in Q2 2025.